Device Trial Radar · NCT05765253
Achieving Portal Access With Scorpion Post-Approval Study (APASS)
Last checked: Nov 19, 2026Latest source record: Dec 11, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
3
Actual
Start
Jul 13, 2023
Primary completion
Oct 16, 2023
Study completion Nov 19, 2023
Sponsor
- Lead sponsor
- Argon Medical DevicesNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Avania
- First posted
- Mar 13, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Creation of the parenchymal tract between the portal vein and the hepatic vein is the most difficult and time consuming step in a TIPS procedure. The purpose of this study is to evaluate portal vein access sets during the TIPS procedure.
Conditions
- Portal Hypertension
- Liver Diseases
- Ascites Hepatic
- Hydrothorax
- Vascular Diseases
Interventions
Scorpion Portal Vein Access KitDevice
Portal Vein Access with Scorpion or Scorpion X set
Cook Transjugular Liver Access SetDevice
Portal Vein Access with Ring or Rosch-Uchida set
Transjugular Intrahepatic Portosystemic Shunt (TIPS)Procedure
Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Procedural SuccessTime frame: TIPS Procedure (Day 0), up to 93 minutes
- Composite of Major ComplicationsTime frame: Through 30 days post-TIPS procedure
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Emory University
Atlanta, Georgia
New York Presbyterian - Columbia University Medical Center
New York, New York
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.